Antiplatelet Activity of Nipecotamides in Experimental Thrombosis in Mice
- 1 February 1994
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 83 (2) , 222-225
- https://doi.org/10.1002/jps.2600830222
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidinesJournal of Medicinal Chemistry, 1992
- Cytosolic ionized calcium in human platelets: The influence of collagen and a novel antiplatelet agentBiochemical and Biophysical Research Communications, 1991
- Chiral resolution of α,α′‐bis[3‐(N,N‐diethylcarbamoyl)piperidino]‐p‐xylene, a novel antiplatelet compoundChirality, 1991
- Preliminary In Vivo Studies on the Platelet Aggregation Inhibitory Activity of α,α′-Bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene Dihydrobromide in Beagle DogsJournal of Pharmaceutical Sciences, 1988
- Comparison of Verapamil and Nifedipine in Thrombosis ModelsExperimental Biology and Medicine, 1986
- Relationships between the chemical constitution of aggregation inhibitors and human blood platelet response profileBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984